Cingulate added Maxim Group as a second sales agent for its existing at-the-market stock offering, which permits the company to sell up to $100 million of common stock over time. The change broadens the group of firms that can handle sales; it does not raise the offering’s stated ceiling.
The company also announced its results for the quarter ended Sept. 30, 2026, and a regulatory update in a separate press release.
Key details
- Two agents can now handle sales. A.G.P./Alliance Global Partners, the original sales agent, is joined by Maxim Group. The amendment took effect Nov. 13, 2026.
- The offering remains capped at up to $100 million. The facility was established in March 2026 and allows Cingulate to sell common shares from time to time. The amendment does not change the stated offering limit.
- No specific share sale is announced. The amendment adds Maxim as an agent; it does not specify that shares were sold, how many might be sold, or when sales would occur.
- Quarterly results and a regulatory update were also announced. The material provided here does not include the financial figures or details of that update.
Plain-English implications
Cingulate has another intermediary available to conduct stock sales under its existing offering. Any shares sold through the facility would increase the number of common shares outstanding, but the amendment itself does not establish that a sale has taken place.